Top compounds associated with response to IZUMO2


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA IU1 CTRPv2 pan-cancer AAC 0.022 0.6
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.017 0.6
mRNA KH-CB19 CTRPv2 pan-cancer AAC -0.026 0.6
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA AM-580 CTRPv2 pan-cancer AAC 0.02 0.6
mRNA Cyclopamine GDSC1000 pan-cancer AAC -0.031 0.6
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.018 0.6
mRNA Imatinib CTRPv2 pan-cancer AAC -0.02 0.6
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC 0.019 0.6
Download CSV